The RSV vaccination eligibility age has been lowered from 60 years to 50 years according to an update on the CDC website.

RSV vaccine access expanded to some people in their 50s, according to CDC website The decision appears on a CDC webpage but wasn’t on the agency’s official adult immunization schedule.

RSV vaccine access expanded to some people in their 50s, according to CDC website The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60 ...

The CDC plans to publish clinical considerations that outline the chronic medical conditions and other risk factors for severe RSV disease to be used under this recommendation.

CDC vaccine advisory panel to study child immunization schedule, recommends RSV shot for babies The meeting was the first made up of RFK Jr.'s new hand-selected members.

In April, the CDC’s influential Advisory Committee on Immunization Practices recommended expanding RSV vaccination to high-risk adults as young as 50, too. But the CDC lacks a director to decide ...

The CDC director typically signs off on the panel's recommendations before they are implemented, but the agency does not currently have one.

A CDC advisory panel on Thursday voted 5-2 to recommend the use of a new preventative RSV therapy in babies, Merck’s Enflonsia.

CDC advisers recommend Merck's Enflonsia to protect babies from RSV, addressing the leading cause of infant hospitalization ...

The U.S. CDC recommends RSV vaccines for high-risk adults aged 50-59, endorsing the views of the former vaccine advisory panel. Read more here.